inhaled insulin

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

MannKind Posts 15% Revenue Growth as CEO Eyes Healthcare Conference Spotlight

MannKind reports 15% Q1 revenue growth to $90.2M; CEO to present at Jefferies conference as company showcases Afrezza pediatric and pregnancy data.
MNKDrevenue growthbiopharmaceutical